Perrigo | PRGO - Bénéfice Avant Impôts





Bénéfice Avant Impôts Changement Date
AbbVie USD 2.67B 1.71B 2025-12
Abbott USD 2.39B 27M 2026-03
Bayer EUR -1.16B 735M 2025-09
Bristol-Myers Squibb USD 3.11B 1.34B 2025-09
Coherus Biosciences USD -46.35M 90.86M 2025-12
Corcept Therapeutics USD 15.24M 16.45M 2025-09
Dr.Reddys Laboratories INR 15.68B 2.38B 2025-12
Eli Lilly USD 7.23B 456M 2025-09
J&J USD 7.82B 2.86B 2026-03
Merck USD 6.74B 22M 2025-09
Nestle CHF 7.24B 1.1B 2024-06
Pacira USD 9.52M 11.45M 2025-09
Perrigo USD 22.4M 19.2M 2025-09
Pfizer USD 3.33B 290M 2025-09
Phibro Animal Health USD 38.62M 1.26M 2025-12
Prestige Brands USD 69.13M 7.35M 2025-09
Reckitt Benckiser GBP 1.54B 73M 2025-06
Sanofi EUR -1.16B 5.5B 2025-12
Supernus Pharmaceuticals USD -1.91M 56.04M 2025-12
Teva Pharmaceutical Industries USD 753M 662M 2026-03
Xeris Pharmaceuticals USD 11.08M 10.46M 2025-12
Zoetis USD 887M 15M 2025-09